Nasdaq Cmrx News Today

Chimerix (NASDAQ:CMRX – Get Free Report) posted its earnings results on Wednesday. The biopharmaceutical company reported ($0.25) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.04), Zacks reports. Chimerix had a negative return on equity of 39.62% and a negative net margin of 25,337.96%. During the same quarter last […]

Chimerix, Inc. (NASDAQ:CMRX – Get Free Report) was the target of a significant decrease in short interest in January. As of January 15th, there was short interest totalling 1,140,000 shares, a decrease of 7.3% from the December 31st total of 1,230,000 shares. Currently, 1.4% of the company’s stock are sold short. Based on an average […]

Chimerix, Inc. (NASDAQ:CMRX – Get Free Report) was the recipient of a significant decline in short interest in the month of December. As of December 15th, there was short interest totalling 1,360,000 shares, a decline of 14.5% from the November 30th total of 1,590,000 shares. Based on an average daily volume of 423,800 shares, the […]

Chimerix, Inc. (NASDAQ:CMRX – Get Free Report)’s share price passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $1.17 and traded as low as $0.97. Chimerix shares last traded at $0.98, with a volume of 403,193 shares changing hands. Analysts Set […]

StockNews.com started coverage on shares of Chimerix (NASDAQ:CMRX – Free Report) in a report released on Thursday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Other analysts have also issued reports about the stock. Robert W. Baird began coverage on shares of Chimerix in a research report on Monday, May 22nd. They […]

Chimerix (NASDAQ:CMRX – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a research note issued to investors on Wednesday, Benzinga reports. They currently have a $11.00 target price on the biopharmaceutical company’s stock. A number of other brokerages have also recently commented on CMRX. Robert W. Baird […]

Chimerix (NASDAQ:CMRX – Get Free Report)‘s stock had its “outperform” rating reaffirmed by analysts at Wedbush in a research report issued to clients and investors on Wednesday, RTT News reports. They currently have a $6.00 price objective on the biopharmaceutical company’s stock. CMRX has been the topic of several other research reports. Robert W. Baird […]

HC Wainwright reaffirmed their buy rating on shares of Chimerix (NASDAQ:CMRX – Free Report) in a research report report published on Friday morning, Benzinga reports. The brokerage currently has a $11.00 target price on the biopharmaceutical company’s stock. Other analysts have also recently issued reports about the company. StockNews.com started coverage on Chimerix in a […]

Chimerix, Inc. (NASDAQ:CMRX – Get Rating) saw a large drop in short interest in the month of May. As of May 15th, there was short interest totalling 3,720,000 shares, a drop of 9.3% from the April 30th total of 4,100,000 shares. Approximately 5.0% of the company’s shares are sold short. Based on an average daily […]

Robert W. Baird assumed coverage on shares of Chimerix (NASDAQ:CMRX – Get Rating) in a research note issued to investors on Monday, The Fly reports. The brokerage issued an outperform rating and a $7.00 price objective on the biopharmaceutical company’s stock. Several other equities research analysts have also recently weighed in on the company. HC […]